Aspirin increases the risk of major bleeding in large study of Italian patients. June 5, 2012— -- For years, the advice for preventing heart disease has been simple: take an aspirin every day; it ...

Baltimore, MD and Oslo, Norway - A new classification for measuring bleeding in clinical trials of antithrombotic agents has been proposed that takes into account minor bleeding more than current ...

Please provide your email address to receive an email when new articles are posted on . Rivaroxaban was linked to higher rates of major bleeding compared with low-dose aspirin. Apixaban and dabigatran ...

The primary efficacy endpoint of clinically-relevant bleeding, defined as BARC types 2, 3 or 5 bleeding, was assessed in the intention-to-treat population between one-month and twelve-months post-PCI ...

Early dual antiplatelet therapy shows superior efficacy in reducing stroke recurrence compared with aspirin monotherapy.